• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Motus GI Holdings Shares Are Trading Lower By Around 46%; Here Are 20 Stocks Moving Premarket

    12/19/23 8:09:17 AM ET
    $AHI
    $BLUE
    $BMRA
    $BYTS
    Package Goods/Cosmetics
    Consumer Discretionary
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $AHI alert in real time by email

    Shares of Motus GI Holdings, Inc. (NASDAQ:MOTS) shares fell sharply in pre-market trading after the company priced its $5 million public offering.

    Motus GI Holdings shares dipped 46.5% to $1.15 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Infobird Co., Ltd (NASDAQ:IFBD) shares rose 128.8% to $3.10 in pre-market trading after the company inked a new business cooperation in software development of information technology system.
    • Jin Medical International Ltd.(NASDAQ:ZJYL) gained 76.7% to $179.96 in pre-market trading after jumping around 264% on Monday.
    • SOBR Safe, Inc. (NASDAQ:SOBR) shares climbed 33.7% to $0.6250 in pre-market trading after declining around 7% on Monday.
    • EG Acquisition Corp. (NYSE:EGGF) shares gained 33.2% to $14.38 in pre-market trading.
    • Nxu, Inc. (NASDAQ:NXU) shares rose 31% to $0.0258 in pre-market trading. Nxu announced that Nasdaq approved company's request for continued listing, subject to Nxu demonstrating compliance with the listing rules on or before April 7, 2024.
    • Panbela Therapeutics, Inc. (NASDAQ:PBLA) shares surged 29.7% to $1.31 in pre-market trading. Panbela Therapeutics shares jumped 120% on Monday after US WorldMeds received FDA approval of eflornithine.
    • Yoshiharu Global Co. (NASDAQ:YOSH) rose 23.1% to $6.30 in pre-market trading.
    • Hanryu Holdings, Inc. (NASDAQ:HRYU) shares gained 18.7% to $1.27 in pre-market trading after falling around 12% on Monday.
    • Sidus Space, Inc. (NASDAQ:SIDU) gained 16.5% to $0.0466 in pre-market trading. Sidus Space shares fell over 20% on Monday after the company announced a 1-for-100 reverse stock split.
    • The NFT Gaming Company, Inc. (NASDAQ:NFTG) shares rose 15.3% to $0.37 in pre-market trading. NFT Gaming Company recently announced newest game launch, Battle Fleet AI.

    Losers

    • ETAO International Co., Ltd. (NASDAQ:ETAO) shares fell 29.4% to $0.3245 in pre-market trading. ETAO International received a staff determination letter, on Dec. 13, 2023, from the Listing Qualifications Department of The Nasdaq Stock Market LLC.
    • bluebird bio, Inc. (NASDAQ:BLUE) shares fell 15.4% to $2.58 in pre-market trading after the company announced a proposed public offering of $150 million of common stock.
    • BYTE Acquisition Corp. (NASDAQ:BYTS) shares fell 15.1% to $8.30 in pre-market trading. BYTE Acquisition reported adjournment of shareholder meeting to approve business combination with Airship AI to 4:00 p.m. ET, Dec. 19, 2023.
    • ZyVersa Therapeutics, Inc. (NASDAQ:ZVSA) fell 13.8% to $0.9220 in pre-market trading after surging 38% on Monday.
    • iCoreConnect Inc. (NASDAQ:ICCT) fell 12.5% to $2.02 in pre-market after jumping over 35% on Monday.
    • Advanced Health Intelligence Ltd. (NASDAQ:AHI) fell 11.5% to $1.70 in pre-market trading. Advanced Health Intelligence said it Will launch medically approved mobile phone-based Atrial Fibrillation assessment in the second quarter of 2024.
    • Ebix, Inc. (NASDAQ:EBIX) shares fell 11.3% to $1.42 in pre-market trading. Ebix shares fell around 67% on Monday after the company and certain US affiliates filed for protection under Chapter 11 and reached a stalking horse agreement to sell its North American Life and Annuity assets to Zinnia.
    • Alaunos Therapeutics, Inc (NASDAQ:TCRT) fell 10.1% to $0.0516 in pre-market trading after jumping 26% on Monday.
    • Biomerica, Inc. (NASDAQ:BMRA) shares fell 9.7% to $1.49 in pre-market trading. Biomerica shares gained around 67% on Monday after the company received FDA 510(k) clearance for its Hp Detect ELISA test product.

     

    Now Read This: Fear & Greed Index Remains In ‘Extreme Greed’ Zone; S&P 500 Settles Higher

    Get the next $AHI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AHI
    $BLUE
    $BMRA
    $BYTS

    CompanyDatePrice TargetRatingAnalyst
    bluebird bio Inc.
    $BLUE
    2/24/2025Underweight → Neutral
    Analyst
    bluebird bio Inc.
    $BLUE
    2/24/2025$29.00Overweight
    Analyst
    bluebird bio Inc.
    $BLUE
    11/18/2024Neutral → Underweight
    Analyst
    bluebird bio Inc.
    $BLUE
    11/15/2024Neutral → Underweight
    JP Morgan
    bluebird bio Inc.
    $BLUE
    11/15/2024$3.00 → $0.50Buy → Neutral
    BofA Securities
    bluebird bio Inc.
    $BLUE
    8/15/2024Overweight → Neutral
    JP Morgan
    Advanced Health Intelligence Ltd.
    $AHI
    5/30/2024Buy → Hold
    Maxim Group
    bluebird bio Inc.
    $BLUE
    12/11/2023Hold → Reduce
    HSBC Securities
    More analyst ratings

    $AHI
    $BLUE
    $BMRA
    $BYTS
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    December 8, 2023 - FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease

    For Immediate Release: December 08, 2023 Today, the U.S. Food and Drug Administration approved two milestone treatments, Casgevy and Lyfgenia, representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older. Additionally, one of these therapies, Casgevy, is the first FDA-approved treatment to utilize a type of novel genome editing technology, signali

    12/8/23 11:12:21 AM ET
    $BLUE
    $VRTX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    August 17, 2022 - FDA Approves First Cell-Based Gene Therapy to Treat Adult and Pediatric Patients with Beta-thalassemia Who Require Regular Blood Transfusions

    For Immediate Release: August 17, 2022 Today, the U.S. Food and Drug Administration approved Zynteglo (betibeglogene autotemcel), the first cell-based gene therapy for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions.  “Today’s approval is an important advance in the treatment of beta-thalassemia, particularly in individuals who require ongoing

    8/17/22 2:12:27 PM ET
    $BLUE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AHI
    $BLUE
    $BMRA
    $BYTS
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    On-Orbit Imagery Milestone with HEO USA's Payload Aboard Sidus Space's Multi-Mission LizzieSat-3

    Images Captured by HEO USA's Non-Earth Imaging Camera Validate Integrated Sensor Performance in Orbit CAPE CANAVERAL, Fla., March 5, 2026 /PRNewswire/ -- Sidus Space, Inc. (NASDAQ:SIDU) ("Sidus" or the "Company"), an innovative space and defense technology company, and HEO USA, a leading provider of non-Earth imaging (NEI) and analytics, today announced the successful receipt of a series of on‑orbit images from HEO USA's NEI camera aboard Sidus Space's LizzieSat‑3 (LS‑3). Sidus Space's LizzieSat‑3 validates integrated multi‑sensor performance with first on‑orbit imagery for HEO

    3/5/26 8:31:00 AM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    Biomerica Receives MHRA Registration for hp+detect™, Allowing Commercial Sales in Great Britain

    UK Market Entry: MHRA registration authorizes hp+detect™ for commercial sale in Great BritainActive Commercialization: Biomerica is in active discussions with UK partners to access the diagnostic laboratory market and expects to provide further updates as agreements are finalized.Disease Burden: The WHO designates H. pylori as a Class 1 carcinogen and lists it among the 16 antibiotic-resistant bacteria posing the greatest global health threat — underscoring the clinical need for accurate diagnostics. IRVINE, Calif., March 05, 2026 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ:BMRA), a global provider of advanced medical diagnostic and therapeutic products, today announced that it has receiv

    3/5/26 8:19:00 AM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders

    The lead drug candidate, ALN1003, showed dose-related body weight loss and favorable body composition changes in the DIO mouse modelALN1003 also demonstrated reductions in liver weight and improvements in select biomarkers associated with liver injury compared to untreated miceEfforts to conduct additional preclinical studies, pursue optimized formulations and refine manufacturing processes are ongoing FORT LAUDERDALE, Fla., March 02, 2026 (GLOBE NEWSWIRE) -- Alaunos Therapeutics, Inc. (NASDAQ:TCRT), an early-stage biotechnology company, today announced early data from two non-Good Laboratory Practice (non-GLP) diet-induced obesity (DIO) mouse studies evaluating ALN1003, the Company's lea

    3/2/26 6:30:57 AM ET
    $TCRT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AHI
    $BLUE
    $BMRA
    $BYTS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Chin Eric was granted 22,500 shares, increasing direct ownership by 225% to 32,500 units (SEC Form 4)

    4 - BIOMERICA INC (0000073290) (Issuer)

    1/28/26 5:40:25 PM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Director Vieser Jaime was granted 5,839 shares, increasing direct ownership by 22% to 32,338 units (SEC Form 4)

    4 - Alaunos Therapeutics, Inc. (0001107421) (Issuer)

    1/15/26 4:15:02 PM ET
    $TCRT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Postma Robert W was granted 5,622 shares, increasing direct ownership by 15% to 43,872 units (SEC Form 4)

    4 - Alaunos Therapeutics, Inc. (0001107421) (Issuer)

    1/15/26 4:15:03 PM ET
    $TCRT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AHI
    $BLUE
    $BMRA
    $BYTS
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Shuman Jeffrey S bought $24,689 worth of shares (15,000 units at $1.65) (SEC Form 4)

    4 - Sidus Space Inc. (0001879726) (Issuer)

    6/13/25 4:15:18 PM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    Large owner Schonfeld Strategic Advisors Llc sold $79,589 worth of shares (41,400 units at $1.92) and bought $372,143 worth of shares (146,800 units at $2.54) (SEC Form 4)

    4 - iCoreConnect Inc. (0001906133) (Issuer)

    4/28/25 6:12:27 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    President Pratt Annie bought $15,246 worth of shares (61,733 units at $0.25), increasing direct ownership by 4% to 508,169 units (SEC Form 4)

    4 - Nxu, Inc. (0001722969) (Issuer)

    3/18/25 4:13:25 PM ET
    $NXU
    Construction/Ag Equipment/Trucks
    Consumer Discretionary

    $AHI
    $BLUE
    $BMRA
    $BYTS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Bluebirdbio upgraded by Analyst

    Analyst upgraded Bluebirdbio from Underweight to Neutral

    2/24/25 7:05:14 AM ET
    $BLUE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Analyst initiated coverage on Bluebirdbio with a new price target

    Analyst initiated coverage of Bluebirdbio with a rating of Overweight and set a new price target of $29.00

    2/24/25 7:04:33 AM ET
    $BLUE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Bluebirdbio downgraded by Analyst

    Analyst downgraded Bluebirdbio from Neutral to Underweight

    11/18/24 4:13:05 AM ET
    $BLUE
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AHI
    $BLUE
    $BMRA
    $BYTS
    SEC Filings

    View All

    ZyVersa Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - ZyVersa Therapeutics, Inc. (0001859007) (Filer)

    3/5/26 4:05:37 PM ET
    $ZVSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Alaunos Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

    8-K - Alaunos Therapeutics, Inc. (0001107421) (Filer)

    3/2/26 6:29:47 AM ET
    $TCRT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form S-8 filed by SOBR Safe Inc.

    S-8 - SOBR Safe, Inc. (0001425627) (Filer)

    2/27/26 5:14:59 PM ET
    $SOBR
    Newspapers/Magazines
    Consumer Discretionary

    $AHI
    $BLUE
    $BMRA
    $BYTS
    Leadership Updates

    Live Leadership Updates

    View All

    Sidus Space Appoints Aerospace Executive Kelle Wendling to Board of Directors

    Veteran Space and Defense Leader Brings Three Decades of Government Contracting, ISR, and Space Systems Expertise to Sidus Board CAPE CANAVERAL, Fla., Jan. 5, 2026 /PRNewswire/ -- Sidus Space, Inc. (NASDAQ:SIDU) ("Sidus" or the "Company"), an innovative space and defense technology company, today announced the appointment of accomplished aerospace and defense executive Kelle Wendling to its Board of Directors. Ms. Wendling brings more than three decades of executive leadership and government contracting experience across space systems, Intelligence, Surveillance and Reconnaissance (ISR), and Federal Aviation Administration (FAA) markets.

    1/5/26 8:30:00 AM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    Gary Huff, Former CEO of LabCorp Diagnostics, Appointed to Biomerica Board of Directors

    Brings decades of leadership in laboratory testing, clinical diagnostics, payor strategy, and sales growth Extensive track record in commercializing advanced laboratory testing and insurer strategies IRVINE, Calif., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ:BMRA), a global provider of advanced diagnostic solutions, today announced the appointment of Gary Huff to its Board of Directors as an independent board member. Mr. Huff brings decades of leadership experience in the diagnostics and healthcare services industry, including serving as Chief Executive Officer of LabCorp Diagnostics, one of the world's largest clinical laboratories. Mr. Huff is a hands-on, inspirational,

    10/8/25 8:19:00 AM ET
    $BMRA
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Sidus Space Appoints Lawrence Hollister as Chief Business Officer to Drive Strategic Growth and Market Expansion

    Sidus Space (NASDAQ:SIDU), (the "Company" or "Sidus"), an innovative space and defense technology company, today announced the appointment of Lawrence Hollister as its new Chief Business Officer, effective September 15, 2025, to accelerate growth across commercial and government markets. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250915521625/en/Sidus Space Appoints Lawrence Hollister as Chief Business Officer Mr. Hollister joins Sidus with a distinguished track record of driving revenue growth, scaling operations, and executing strategic initiatives across defense, aerospace, intelligence, cyber, and federal civil sectors.

    9/15/25 8:30:00 AM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    $AHI
    $BLUE
    $BMRA
    $BYTS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by iCoreConnect Inc.

    SC 13G/A - iCoreConnect Inc. (0001906133) (Subject)

    12/12/24 9:44:00 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by iCoreConnect Inc.

    SC 13G/A - iCoreConnect Inc. (0001906133) (Subject)

    12/5/24 4:08:58 PM ET
    $ICCT
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by Sidus Space Inc.

    SC 13G/A - Sidus Space Inc. (0001879726) (Subject)

    11/14/24 7:31:47 PM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    $AHI
    $BLUE
    $BMRA
    $BYTS
    Financials

    Live finance-specific insights

    View All

    ZyVersa Therapeutics Reports Third Quarter 2025 Financial Results

    ZyVersa is advancing a therapeutic development pipeline with multiple programs built around its two proprietary technologies – Cholesterol Efflux Mediator VAR 200 for treatment of kidney diseases, and Inflammasome ASC Inhibitor IC 100 for treatment of chronic inflammatory diseases.The lead indication for VAR 200 is focal segmental glomerulosclerosis (FSGS) with potential indication expansion in Alport syndrome and diabetic kidney disease.The lead indication for IC 100 is cardiometabolic conditions, with potential indication expansion in rare kidney diseases.Raised approximately $2.05 million in Q3-2025; $4.05 million year-to-date. WESTON, Fla., Nov. 19, 2025 (GLOBE NEWSWIRE) -- ZyVersa Th

    11/19/25 4:20:00 PM ET
    $ZVSA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sidus Space Reports Third Quarter 2025 Financial Results and Provides Business Update

    Sidus Space (NASDAQ:SIDU), (the "Company" or "Sidus"), an innovative space and defense technology company, today announced its financial results for the third quarter ended September 30, 2025, and provided a business update. The Company is scheduled to host a conference call and webcast today, Friday, November 14, at 5:00 p.m. ET. "Q3 was about executing on existing contracts and furthering our efforts to expand our vertically integrated product offerings. We continued laying the groundwork to convert our technology foundation into meaningful commercial opportunities. We advanced design and manufacturing across multiple LizzieSat® platforms, broadened our Fortis™ VPX and FeatherEdge™ prod

    11/14/25 4:45:00 PM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications

    Sidus Space to Host Third Quarter Financial Results Conference Call on November 14 at 5:00 p.m. ET

    Sidus Space (NASDAQ:SIDU), (the "Company" or "Sidus"), a vertically integrated space and defense technology provider, today announced that it will host its third quarter 2025 financial results conference call at 5:00 p.m. Eastern Time on Friday, November 14, 2025. Event: Sidus Space Third Quarter Financial Results Conference Call Date: Friday, November 14, 2025 Time: 5:00 p.m. Eastern Time Live Call: + 1-877-269-7751 (U.S. Toll-Free) or +1-201-389-0908 (International) Webcast: https://viavid.webcasts.com/starthere.jsp?ei=1742231&tp_key=afa35717c1 For interested individuals unable to join the conference call, a dial-in replay of the call will be available until Friday, November 28, 202

    11/7/25 8:30:00 AM ET
    $SIDU
    Telecommunications Equipment
    Telecommunications